Lancet Oncology reports safety and efficacy of Holmium-166 SIRT after PRRT

News: Lancet Oncology reports

Terumo Europe N.V. and Quirem Medical B.V are proud to share the latest key publication regarding holmium-166 (QuiremSpheres®) Selective Internal Radiation Therapy (SIRT). On 27 February 2020, the UMC Utrecht published their latest results in the Lancet Oncology Journal from the non-randomized HEPAR PLuS study. The study enrolled neuroendocrine tumor (NET) patients with liver disease […]